Expanding Diverse and Innovative Collaborations to Co-create a Healthier China

ShanghaiNovember 7, 2022PR Newswire -- As the health demands of Chinese consumers continue to evolve from "treating illnesses" to "healthy living," Bayer HealthCare Consumer Products, with a global perspective, is leveraging the opportunities of openness to further expand its local "circle of friends" at the fifth China International Import Expo, meeting the multi-layered health needs of Chinese consumers through innovative thinking.

During the exhibition, Bayer HealthCare Consumer Products, in collaboration with Professor Ma Guansheng's team from Peking University School of Public Health, held the unveiling ceremony for the "Science and Technology Innovation in China" Smart Health Professional Technology Service Group Expert Workstation, and launched the first professional technology service project, the "Nutrition Literacy Improvement Plan." Bayer also expanded its existing strategic cooperation with Jiangnan University to jointly establish the "Probiotics Science Innovation Laboratory," seeking answers for healthy foods within gut microbiota. Additionally, Bayer signed a strategic cooperation agreement with Shandong Xinhua Pharmaceutical Company Limited to deepen and broaden category innovation and global supply chain collaboration, while also signing a project cooperation agreement with Colori INC. to co-develop daily care solutions targeting scalp health.

The launch of various collaborations will further leverage the strengths of Bayer HealthCare Consumer Products and its partners in academic research, product development, production technology, and supply chain management. This will enhance Bayer HealthCare Consumer Products' capabilities in theoretical research, innovation transformation, health product development, and supply chain optimization, providing comprehensive support for Bayer HealthCare Consumer Products to offer innovative, high-quality, scientifically proven safe and effective diversified solutions to the Chinese people. Leaders from Bayer HealthCare Consumer Products and related academic institutions, associations, and enterprises attended the event.

Bayer HealthCare China General Manager He Yong stated, "In China, for China" is Bayer's commitment. In fulfilling this commitment, close cooperation with Chinese academic institutions, research institutes, local enterprises, and industry associations is indispensable. We will accelerate the pace of innovation, strengthen the foundation of cooperation, enhance service capabilities, and work together with all parties to build a "Healthy China," contributing more to the advancement of the health cause of the Chinese people.

Integration of industry, academia, and research to create a high ground for scientific research and academia, assisting"Proactive Health"Quality Improvement

The "SciTech China" Smart Health Professional Science and Technology Service Group of Peking University, centered around the School of Public Health at Peking University, was jointly established with regional science associations, universities, and enterprises. It fully leverages the research capabilities of higher education and research institutions, strengthens industry-university-research collaboration, and establishes a multi-party connection mechanism. Through technological support such as technology transfer, professional technical services, and information platform construction, it builds a comprehensive and multi-dimensional scientific research service framework in the field of nutrition and health. By seizing the development opportunities in the nutrition and health sector, it accelerates the construction of Healthy China and promotes the realization of universal health. The establishment of the expert workstation at Bayer HealthCare Consumer Products is one of the manifestations of the integrated model of industry-university-research health services. With the workstation as a carrier, expert resources will be concentrated into the enterprise to provide consultation and training empowerment. Combined with market research, it guides enterprises to accurately align the needs of the nutrition and health industry with technological implementation, facilitating the transformation and application of technological achievements.

The first professional technology service project "Nutrition Literacy Improvement Program" has officially started. This program, hosted by the China Health Promotion and Education Association, with technical support from the "SciTech China" Intelligent Health Professional Technology Service Group and participation from Bayer HealthCare Consumer Products, is a national public welfare project aimed at promoting nutrition literacy among Chinese citizens and supporting Healthy China.

It is reported that the "Nutrition Literacy Improvement Program" will be carried out in two phases. The first phase will focus on clinical doctors in first-tier cities and revolve around the theme of "Common Nutrients and Immunity Enhancement" to conduct surveys, thereby understanding clinical doctors' awareness of nutrients and immunity. After the questionnaires are collected, a survey report will be generated. Meanwhile, the Peking University "SciTech Innovation in China" Intelligent Health Professional Technology Service Group will carry out scientific evidence collection on common nutrients and immunity and form a scientific review accordingly. At that time, the two reports will be released together to the public. In the future, the project will also rely on the "National Nutrition Literacy Assessment Tool" to evaluate the nutrition literacy of various groups, thereby carrying out targeted, multi-channel public health science communication and promotion activities.

Based on the successful cooperation between Bayer and Jiangnan University in the field of gastrointestinal health over the past two years, the two parties signed a strategic cooperation agreement again at this year's CIIE to expand the breadth and depth of their existing partnership. They will jointly establish the "Probiotics Science Innovation Lab," fully leveraging their respective strengths. Based on consumer insights, they will jointly develop new functions of probiotics, aiming to explore solutions for healthy food from probiotics to meet the unmet needs of Chinese consumers for health products and services. In the future, the cooperation between Bayer and Jiangnan University will not be limited to gut health but will also extend to multiple fields such as immune regulation, allergy management, and prevention.

Bayer HealthCare Consumer Products China General Manager He Yong (fourth from the left), Jiangnan University President Chen Wei, Academician (third from the right)

Expand Local Innovation Cooperation, Win-Win for a Healthy China Future

Bayer HealthCare has been committed to providing consumers with innovative, high-quality, scientifically proven safe and effective diversified solutions. The synergistic cooperation with local innovative enterprises in China has provided more options for the realization of this goal and injected new momentum.

During the CIIE, Bayer HealthCare LLC and Shandong Xinhua Pharmaceutical Company Limited signed a strategic cooperation agreement based on 15 years of successful collaboration. This agreement aims to expand the scale of existing cooperative projects. In the future, Bayer will fully leverage Xinhua Pharmaceutical's robust R&D innovation capabilities, multi-dosage form formulation technologies, and global supply chain coverage to provide strong support for the R&D and production of locally produced products in China, deepening and optimizing the global supply chain layout. Meanwhile, the scope of cooperation between the two parties will also expand from the current nutrition category to include digestive health, pain management, and dry cough categories.

Bayer HealthCare Consumer Products China General Manager He Yong (left) Shandong Xinhua Pharmaceutical Company Limited Chairman He Tongqing

Skin Health: A Key Focus Area for Bayer's Consumer Health Division with Extensive Global Expertise and Local Insights

Bayer HealthCare Consumer Products China General Manager He Yong (left three), Longliqi Group Chairman Xu Zhiwei (right three)

As one of the earliest multinational enterprises to enter the Chinese market, over the past 140 years, Bayer has continuously increased its investment in product research and development, introduced innovative products, and expanded diverse collaborations, providing Chinese consumers with a steady stream of more, newer, and better health solutions and innovative products, nurturing the health of several generations. Today, China has become one of the most important strategic pillars for Bayer's global business and the second-largest market for its consumer health division.

With the shift from "disease-centered" to "people's health-centered" philosophy, Bayer HealthCare will continue to enhance its comprehensive capabilities in scientific research, product development, manufacturing, market supply, and public education. By gaining insights into local consumers, leveraging global resources, and utilizing worldwide experience and pipeline advantages, Bayer actively explores diversified cooperation models with innovative enterprises, universities, and research centers in China. Through continuous innovation in products and service methods, Bayer provides Chinese consumers with high-quality, scientifically proven self-care solutions, becoming a trusted partner for the public.

Forward-Looking Statements

This press release includes forward-looking statements by the management of Bayer Group based on current assumptions and forecasts. Various known and unknown risks, uncertainties, and other factors could cause the company's actual operational results, financial condition, development, or performance to differ materially from the estimates made in the above forward-looking statements. These factors are detailed on Bayer's official website.www.bayer.comThe various reports of Bayer disclosed. The Company has no responsibility to update these forward-looking statements or to make them conform to future events or developments.